X

Xeris Pharmaceuticals, Inc. Tech Stack

Biopharmaceutical manufacturer scaling commercial operations and clinical trials

Pharmaceutical Manufacturing Chicago, Illinois 201–500 employees Founded 2005 Public Company

Xeris is a biopharmaceutical company with 201–500 employees focused on drug development and commercialization. The hiring mix reflects a sales-led commercial phase: 31 open roles in sales versus 7 in research, paired with active initiatives in regulatory submissions, phase 3 trials (XP-8121), and patient access programs. Tech stack is pharma-standard (IQVIA, SAS, Veeva PromoMats, CDISC) with notable pain points around patient reimbursement barriers and clinical trial supply-chain execution—typical friction points for mid-stage biotech scaling beyond preclinical work.

Tech Stack 18 technologies

Core StackSAS Lattice Excel SQL IQVIA R CDISC Outlook Word PowerPoint Teams SharePoint Microsoft 365 Windows Microsoft Office HPLC UHPLC Veeva PromoMats

What Xeris Pharmaceuticals, Inc. Is Building

◆Challenges

Barriers to progress
Patient access to products
Cross functional program risk mitigation
Optimizing reimbursement processes
Expanding patient access
Strengthening partnerships
New clinical trial supply chain execution
Low technology roi
Patient access to therapies
Patient reimbursement barriers

▲Active Projects

Regulatory submissions
Ancillary supplies forecasting and distribution
Drug labeling and packaging strategy implementation
Sop development
Marketing mix modeling
Xp-8121 phase 3 trial
Regional business plans
Dashboard design for patient assistance team
Method sourcing for formulation development
Promotional speaker programs

Hiring Activity

Steady65 roles · 20 in 30d

Department

Sales

31

Research

7

Healthcare

4

Ops

3

Product

3

Data

2

Finance

2

Legal

2

Seniority

Senior

24

Mid

18

Director

11

Junior

6

Manager

4

Intern

1

VP

1

Notable leadership hires: Medical Director, Regional Business Director, Business Director, Market Access Director

Company intelligence

Find more companies like Xeris Pharmaceuticals, Inc. by tech stack, pain points and active projects

Get started free

About Xeris Pharmaceuticals, Inc.

Xeris develops and commercializes pharmaceutical products across multiple therapeutic areas, serving patient populations through a combination of drug development and market access initiatives. Based in Chicago and founded in 2005, the company operates at the intersection of regulatory compliance, clinical operations, and commercial sales. Active projects include a phase 3 trial for XP-8121, ancillary supplies forecasting, drug labeling strategy, and patient assistance dashboards. The organization spans United States, Canada, and Peru hiring footprints, with leadership roles concentrated in medical, regional business, and market access functions.

HeadquartersChicago, Illinois

Company Size201–500 employees

Founded2005

Hiring MarketsUnited States, Peru, Canada

Frequently Asked Questions

What is Xeris Pharmaceuticals' tech stack?

Core tools include IQVIA, SAS, R, and CDISC for regulatory work; Veeva PromoMats for promotional materials; Excel and SQL for analytics; and Microsoft 365 (Teams, SharePoint, Office) for collaboration.